An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
for Metastatic Hormone-sensitive Prostate Cancer
Drug: JSB462
Sites in Denver +20 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18+
Code: NCT06991556·Phase 2·Recruiting·Listed May 2025